GlassScriptPhysician profile
Anna K Bareiss
NPI 1508398629
$2,376.11
in general payments reported to CMS, 2019-2025
12 companies · $801 in 2025
The $801 reported for 2025 was more than what 75% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $235 · 2023: $490 · 2024: $850 · 2025: $801.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,141.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,141.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $603.65 | 2024-2025 | Inspire |
| Neurent Medical Limited | $359.88 | 2023-2024 | Neuromark Radiofrequency Console, Neuromark Device |
| Cochlear Americas | $312.56 | 2023-2025 | Baha, Cochlear Nucleus Ci632 Cochlear Implant With Slim Modiolar Electrode, Osia Osi300 Implant |
| Advanced Bionics, LLC | $183.40 | 2024 | Hires Ultra Ci Hifocus Ms Electrode |
| Medtronic, INC. | $174.02 | 2022-2025 | Nuvent |
| Stryker Corporation | $170.30 | 2023-2025 | Scopis Ent, Audion Et Dilation System |
| Smith+Nephew, INC. | $167.32 | 2023-2025 | Tula, Coblation, Ent Sinus |
| Med-El Corporation | $135.57 | 2022-2025 | Mi1250 Synchrony 2 Flexsoft, Bci 602 Kit |
| Acclarent, INC | $126.50 | 2023 | Acclarent Navwire, Acclarent Aera |
| Grace Medical, INC. | $60.65 | 2023 | |
| Aerin Medical INC. | $54.87 | 2024 | |
| Optinose US, INC. | $27.39 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anna Bareiss listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.